Louvre Discreetly Removes Sackler Name Amid Opioid Scandal
Juy 18th 2019
The Louvre museum in Paris has removed the name of the Sackler family from one of its wings, amid a sanitory scandal that has seen the billionaire donors accusedof pushing a highly-addictive opioid blamed for tens of thousands of deaths, reported local media on Wednesday.4
Louvre president Jean-Luc Martinez said on RTL television on Tuesday that the rooms no longer carried the name as such a tribute lasted a maximum of 20 years after the donation.
This would mean that the Sackler wing should not have been named after the family for several years. But the Louvre spokesperson declined to comment when asked why the name had not been removed three years ago.
Masking tape has been put in place to hide the Sackler name on plaques in the rooms of what had been the Sackler Wing of Oriental Antiquities, which houses artefacts from the ancient Near East.
A museum spokesperson could not say when the tape had been put in place. The wing had been given the name due to a US$3.6 million donation made by the Sackler family in 1996.
American group PAIN (Prescription Addiction Intervention Now), backed by American photographer Nancy Goldin, a former opioid addict, had urged the museum to rename the Sackler Wing.
The Louvre was the latest in a string of museums to face criticism over links to the Sackler family and their company Purdue Pharma, whose painkiller OxyContin is now subject to more than 1,000 lawsuits over its role in the U.S. opioid crisis.
In recent months, galleries including New York's Guggenheim and Metropolitan Museum, and London's Tate and National Portrait Gallery, said they would stop accepting donations from the family.
In 2017, 47,000 people died in the United States as a result of overdosing on opioids including prescription drugs, heroin and fentanyl, the Centers for Disease Control says.
There are hundreds of lawsuits in various U.S. states against both Purdue and its owner the Sackler family, who are accused of pushing for the prescription of OxyContin despite knowing how addictive it is.
But worries about the medication are not confined to the United States.
Last month, around 100 French doctors warned about the risk of a health crisis claiming there were "12 million people in France taking opioids" who had not been told about the potential for addiction and risk of overdose.
Posted with permission